1. Ryder, S., Salom, I., Jacob, G., et al. Etodolac (Ultradol®): The safety profile of a new structurally novel nonsteroidal anti-inflammatory drug. Curr Ther Res 1983, 6, 948–965.
2. Sanda, M., Jacob, G., Shand, D.B. A safety profile of etodolac in arthritis: clinical experience based on 600 patient-years. Today Ther Trend 1985, 1, 1–15.
3. Mullane, J.F. Safety profile of etodolac in arthritis patients. Postgrad Med: Custom Communications 1985, 12, 40–46.
4. Arnold, J.D., Salom, I.L., Berger, A.E., et al. Comparison of gastrointestinal microbleeding associated with use of etodolac, ibuprofen, indomethacin, and naproxen in normal subjects. Curr Ther Res 1985, 4, 730–738.
5. Taggart, H.M., Alderdice, J.M. Fatal cholestatic jaundice in elderly patients taking benoxaprofen. Br Med J 1982, 284, 1372.